More than chromosomes.
Standard IVF genetic testing tells you whether an embryo has the right number of chromosomes. Reticular goes further — using the same data you already have to predict health risks across dozens of traits.
What standard testing misses
PGT-A (preimplantation genetic testing) is now routine in IVF. It screens embryos for chromosomal abnormalities — extra or missing chromosomes — and helps identify which embryos are most likely to result in a healthy pregnancy. But chromosomal problems are just one piece of the picture. Most common diseases — heart disease, type 2 diabetes, certain cancers — aren't caused by a single chromosome error. They're shaped by hundreds or thousands of small genetic variations working together.
What polygenic scores are
A polygenic score adds up genetic signals from across the entire genome to estimate a person's likelihood of developing a given condition. Think of it as a risk forecast built from thousands of small clues rather than a single red flag. Polygenic scores are already used in adult medicine to guide screening and prevention. Reticular applies the same science at the embryo stage — giving families information they've never had access to before.
No new tests required
Reticular works with the genetic data your clinic already collects during PGT-A. There's no additional biopsy, no extra procedure, and no additional wait. We analyze the existing sequencing data and return polygenic scores for a range of traits — so you and your care team can make more informed decisions about which embryo to transfer.
What we screen for
Our polygenic scores cover conditions where genetic risk is well-established and medically actionable, including:
- Cardiovascular disease
- Type 2 diabetes
- Breast and prostate cancer
- Inflammatory conditions
- Mental health disorders
Want to learn whether Reticular is available through your clinic, or have questions about how polygenic scores work?
Book a call